Arch Therapeutics Announces Participation at the 2013 Boulder Peptide Symposium in Colorado September 25-27
20 sept. 2013 09h00 HE
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Sep 20, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), today announced it will be featured as a presenting company at the Boulder Peptide...
Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
14 avr. 2009 08h00 HE
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...